Caidya
PrivateLast Round
Private Equity
Jan 13, 2025
Total Funding Raised
$440.6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Caidya is a global, full-service contract research organization (CRO) that provides clinical development services, including regulatory strategy, clinical operations, and data management, to support biopharmaceutical innovators.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Biotechnology, Drug Discovery, Compliance
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Caidya Comparables
Compare Caidya with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novotech Health Holdings | 92% | |
| Worldwide Clinical Trials | 89% | |
| ClinChoice | 89% |
Caidya Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Jan 13, 2025 | ||||
| Series C Extension | Jul 7, 2021 | ||||
| Series C | Dec 17, 2020 | ||||
| Series B | Oct 16, 2019 | ||||
| Series A | Aug 14, 2018 | ||||
Seed | Nov 30, 2016 |
Key People
Founding team and executive leadership
Caidya Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SpringHill Management | Series C Extension |
| Morgan Stanley Expansion Capital | Private Equity, Series C |
| Hatteras Venture Partners | Private Equity, Series C, Series B |
| Fidelity Management & Research Company | Series C |
| Legend Capital | Series B |
| Harbert Growth Partners | Private Equity |
| Kaiser Foundation Hospitals | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 25, 2026
Pfizer appears to be a new client, based on job postings.
- Feb 17, 2026
Michael Clay appointed as the new COO.
Caidya Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Caidya's valuation, stock price, and market status.
Is Caidya a public or private company?
Caidya is a private company.
What is the current stock price of Caidya?
Caidya is a private company, so its shares have no public market price. Caplight tracks Caidya's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Caidya worth (valuation)?
Valuation information for Caidya is not publicly available.
Can I buy Caidya stock?
Caidya shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Caidya's last funding round?
Caidya's most recent funding round was Private Equity on January 13, 2025.
Who are the main investors in Caidya?
Key investors in Caidya include SpringHill Management, Morgan Stanley Expansion Capital, Hatteras Venture Partners, Fidelity Management & Research Company, Virgo Investment Group.
Will Caidya IPO soon?
No public IPO plans have been announced for Caidya.
How can I track Caidya secondary market activity?
Caplight tracks bids, offers, and trades in Caidya's shares on secondary markets.